Appleton Group’s Johnson & Johnson JNJ Stock Holding History

Appleton Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,130	Closed	-$201K	–	26
2022 Q2	$201K	Hold	1,130	–	–	1.17%	26
2022 Q1	$200K	Buy	+1,130	New	+$192K	0.28%	43

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Appleton Group's JNJ Position: Q3 2022 in Review

Appleton Group sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 1,130 shares — an estimated $201K sold.

Appleton Group first reported a position in JNJ in Q1 2022 and held it in 2 quarters. The position peaked at $201K in Q2 2022. 3,623 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

Appleton Group reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
Appleton Group sold 1,130 Johnson & Johnson shares in Q3 2022, an estimated $201K.
Appleton Group first reported a position in Johnson & Johnson in Q1 2022 and held it in 2 quarters.
Appleton Group's Johnson & Johnson position peaked at $201K in Q2 2022.
3,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Appleton Group's 13F filing for Q3 2022, filed 8 Nov 2022.